ArticleCancer management and research2022

Programmed Cell Death-1 and Its Ligands as Targets for Therapy of Multiple Myeloma Patients.

Agnieszka Karczmarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.